The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancer.
- 2024-01-09
- Clinical Trial · n = 18
- Breast cancer research and treatment 204(3)
- Ingrid V Bonilla Valente
- Denise Garcia
- Andrea Abbott
- Laura Spruill
- Julie Siegel
- Jessica Forcucci
- George Hanna
- Rupak Mukherjee
- Mark Hamann
- Eleanor Hilliard
- Mark Lockett
- David J Cole
- Nancy Klauber-DeMore
- PubMed: 38194131
- DOI: 10.1007/s10549-023-07215-4
- Moderate evidence
- Clinical
There was no difference in change in apoptosis.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 2400 mg/day